Author page: Kathrin Folkendt

How Hybrid Care Startup Oya Is Setting New Standards for Women’s and Reproductive Health in Brazil

Two years have passed since Oya Care announced its $3 million seed funding round, secured from Susa Ventures, with additional investment from Brazilian entities Canary, Positive, and IKJ. In that time, the company has made significant progress, prompting us to sit down with Stephanie von Staa Toledo, Oya’s Founder & CEO, to discuss her journey as she works to position Oya as…

SteelSky Ventures’ Maria Toler: “This infusion of capital into an industry that has remained underfunded will supercharge growth of important innovations in women’s healthcare.”

Most of you will likely be aware of the significant commitment made by the Biden administration toward women’s health research, with First Lady Jill Biden recently announcing a pivotal investment of $100 million during an ARPA-H forum in Cambridge. However, what you may not have known is the active involvement of women’s health-focused VC fund SteelSky Ventures in this groundbreaking initiative. In…

Elidah Secures Series A Funding to Advance Women’s Health Innovations Addressing Urinary Incontinence

Elidah, a healthcare technology company known for developing FDA-cleared non-invasive, wearable treatments for urinary incontinence in women, has recently announced the completion of its Series A funding round. The company has successfully secured an undisclosed amount of investment, led by Blu Venture Investors and supported by contributions from Right Side Capital and Integral Private Wealth Advisors. This financial milestone is set to…

Proov Launches Comprehensive At-Home Fertility Program as Affordable IVF Alternative

Reproductive health company Proov has recently launched the Proov Path to Pregnancy, a new at-home fertility treatment program offering a less invasive and more affordable option compared to traditional in-vitro fertilization (IVF). Amy Beckley, CEO and Founder of Proov, was inspired to create this program based on her personal challenges with infertility, aiming to provide easier access to effective fertility solutions. “In…

Amazon Aggregator Forum Brands Acquires Organic Period Care Brand Lola

Forum Brands, an aggregator specializing in Amazon-focused brands, has acquired Lola, a company known for its organic period care products. Lola, established in 2014 by Alexandra Friedman and Jordana Kier, differentiates itself in the market with its 100% organic cotton tampons, pads, and sanitary products. The acquisition, terms of which were not disclosed, aligns with Forum Brands’ strategy to expand in health…

Spotlight: Maternal Health

Following last week’s Inner Circle Webinar on maternal health innovation, today it’s time for a follow-up and closer look at this critical field in our weekly brief. If you missed last week’s session: Don’t you worry, we’ll also share access to the recording with you.Let’s jump right in and delve deeper into this important topic. 👇 Maternal health is a key component in shaping the health of…

Roche Simplifies PCOS Diagnosis with New CE-Marked Blood Test

Roche Diagnostics has recently received CE-mark regulatory approval for a novel method of diagnosing Polycystic Ovary Syndrome (PCOS), a common endocrine disorder affecting approximately 1 in 8 women of reproductive age. The newly approved Elecsys Anti-Müllerian Hormone (AMH) Plus immunoassay, previously used in fertility diagnostics, now offers a non-invasive alternative to the traditional transvaginal ultrasound for diagnosing PCOS. PCOS, characterized by a…

Autoimmune Benefits: The Next Big Thing in Workplace Health Initiatives?

The evolution of workplace health benefits is a testament to the growing awareness and sensitivity towards diverse employee needs. From mental health support to fertility and menopause benefits, employers have increasingly embraced a holistic approach to employee well-being over the past years. Now, with the recent announcement from WellTheory and Maven Clinic, there’s a compelling case that autoimmune benefits might just be…